Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAW039 Dose-Ranging Trial in Moderate-to-Severe Allergic Asthma
2011-001062-18Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fevipiprant in allergic asthma, sponsored by Novartis. Started Jul 2011; status: completed.
02
Drugs
fevipiprant
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2011-001062-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001062-18.